soul trial oral semaglutide cardiovascular outcomes 2025 🧿 is the first oral GLP-1 RA proven to reduce MACE in high-risk T2DM patients, extending protection beyond injectable formulations. Trial: Oral Semaglutide & Cardiovascular in T2DM SOUL trial shows oral semaglutide

It appears to be efficacious with similar doses to oral treatment, although it appears there may be more variability in compliance and thyroid concentrations 10

Made with adaptogens and botanicals, this formula is free from artificial chemicals, fillers, and GMOs, offering pure, potent herbal support

Understanding this market position helps set appropriate expectations for product quality, testing depth, and pricing structures

**UL: tolerable upper intake level defined as the maximum chronic daily intake of a nutrient

Plateaus occur due to metabolic adaptation, where the body adjusts energy expenditure in response to sustained weight loss, alongside changes in body composition and variable medication response over time

Research indicates that raising glycine levels can promote deeper, more restful sleep and stabilize mood by optimizing NMDA-receptor function